Studies have demonstrated the importance of ferroptosis in tumor progression; however, the molecular triggers of ferroptosis remain unclear.[8, 11] Our data confirmed that CARM1 inhibited ferroptosis by directly interacting with and methylating ACSL4 at R339. Here, ACSL4 is linked to neoplasm.